| Title |
Author |
Type |
Date |
Words |
| Anupam Kher calls Sonali Bendre a hero. |
|
|
Aug 12, 2018 |
182 |
| Bad cholesterol helps cancer spread: Study. |
|
|
Aug 9, 2018 |
230 |
| Germany : How cancer cells hibernate. |
|
|
Aug 9, 2018 |
465 |
| Lipomet: Dietary influences on metastasis: How, When, And why. |
|
|
Aug 7, 2018 |
373 |
| Rapper C Struggs dead at 32 after cancer 'rips through his body' in days; The Dallas-based rapper has died after doctors gave him just eight weeks to live. |
|
|
Aug 4, 2018 |
570 |
| Sonali Bendre is stable, says husband Goldie Behl. |
|
|
Aug 3, 2018 |
159 |
| Sonali Bendre a fighter, says Omung Kumar. |
|
|
Aug 1, 2018 |
262 |
| FDA Grants Breakthrough Therapy Designation for Lenvima/Keytruda Combination as Therapy for Previously Treated Patients with Advanced and/or Metastatic non-MSI-H/pMMR Endometrial Carcinoma. |
|
|
Aug 1, 2018 |
756 |
| Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA. |
|
|
Jul 31, 2018 |
1616 |
| Diagnostic accuracy of glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours. |
|
|
Jul 25, 2018 |
1337 |
| Clinicopathological prognostic factors of oral squamous cell carcinoma: An experience of a tertiary care hospital. |
|
Report |
Jul 25, 2018 |
2869 |
| Calcified dural based meningioma, mimicker of metastasis on skeletal scintigraphy. |
|
|
Jul 25, 2018 |
422 |
| Detection of sputum cofilin-1 as indicator of malignancy. |
Rangel, M.P.; Antonangelo, L.; Acencio, M.M.P.; Faria, C.S.; de Sa, V.K.; Leao, P.S.; Farhat, C.; Fa |
|
Jul 25, 2018 |
3422 |
| US FDA accepts Immunomedics' biologics license application for sacituzumab govitecan. |
|
|
Jul 20, 2018 |
140 |
| US FDA accepts Immunomedics' biologics license application for sacituzumab govitecan. |
|
|
Jul 20, 2018 |
136 |
| United States : FDA grants Breakthrough Therapy Designation for Roches Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC). |
|
|
Jul 18, 2018 |
437 |
| United States : FDA Grants Breakthrough Therapy Designation for Genentechs TECENTRIQ in Combination With Avastin as First-Line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC). |
|
|
Jul 18, 2018 |
492 |
| United States : Anti-PD-L1 Immunotherapy Plus ABRAXANE Significantly Reduced the Risk of Disease Worsening or Death in Patients with Metastatic or Locally Advanced Triple Negative Breast Cancer in Phase III IMpassion130 Study. |
|
|
Jul 13, 2018 |
282 |
| United States : Seattle Genetics Announces Publication of Results from Two Tucatinib Phase 1b Clinical Trials in HER2-Positive Metastatic Breast Cancer. |
|
Financial report |
Jul 13, 2018 |
873 |
| United States : Seattle Genetics and Astellas Announce Progress in Enfortumab Vedotin Urothelial Cancer Clinical Development Program. |
|
|
Jul 13, 2018 |
388 |
| Pfizer reports FDA approves sNDA to broaden XTANDI indication. |
|
|
Jul 13, 2018 |
110 |
| Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. |
|
|
Jul 12, 2018 |
315 |
| Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. |
|
|
Jul 12, 2018 |
310 |
| Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. |
|
|
Jul 12, 2018 |
314 |
| Sonali Bendre weeps as her long hair gets cut off ahead of cancer treatment; The actress revealed she was trying to remain positive after being diagnosed with metastatic cancer this month. |
|
|
Jul 11, 2018 |
372 |
| Bristol-Myers' Opdivo approved for MSI-H/dMMR metastatic colorectal cancer. |
|
|
Jul 11, 2018 |
267 |
| Seattle Genetics announces results of two Phase 1b trials. |
|
Financial report |
Jul 11, 2018 |
319 |
| VBL says data shows MOSPD2 can play major role in breast cancer cell migration. |
|
|
Jul 10, 2018 |
190 |
| Canada : Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer. |
|
|
Jul 9, 2018 |
257 |
| Metastasis: Understanding high-grade cancer. |
|
|
Jul 6, 2018 |
597 |
| United States : LYNPARZA (olaparib) Approved in Japan for BRCA-Mutated Metastatic Breast Cancer. |
|
|
Jul 6, 2018 |
371 |
| United States : FDA Grants Priority Review to Mercks Supplemental Biologics License Application for KEYTRUDA (pembrolizumab) in Combination with Chemotherapy as First-Line Treatment for Metastatic Squamous Non-Small Cell Lung Cancer. |
|
|
Jul 6, 2018 |
265 |
| US FDA Approval Granted to Combination Braftovi with Mektovi for Metastatic Melanoma. |
|
|
Jul 2, 2018 |
194 |
| Novartis Funds Metastatic Breast Cancer Advocacy Groups through STEP Program. |
|
|
Jul 2, 2018 |
191 |
| Halo Publishing International, Inc. Publishes "Handle With Love: One Woman's Approach to Kicking a Nasty Cancer". |
|
|
Jul 2, 2018 |
511 |
| LYNPARZA approved in Japan for BRCA-mutated metastatic breast cancer. |
|
|
Jul 2, 2018 |
200 |
| A Multi-Pronged Attack Against Prostate Cancer. |
|
|
Jul 1, 2018 |
1202 |
| Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth. |
Johnson, Daniel N.; Furtado, Larissa V.; Long, Bradley C.; Zhen, Chao Jie; Wurst, Michelle; Mujacic, |
|
Jul 1, 2018 |
9299 |
| Performance Characteristics of Cerebrospinal Fluid Cytology: An Analysis of Responses From the College of American Pathologists Nongynecologic Cytopathology Education Program. |
Tabatabai, Z. Laura; Auger, Manon; Souers, Rhona J.; Teot, Lisa; Davey, Diane D. |
|
Jul 1, 2018 |
3417 |
| Array BioPharma wins US FDA approval for BRAFTOVI & MEKTOVI combination for treating metastatic melanoma. |
|
|
Jun 28, 2018 |
266 |
| Presbyterian/St. Luke's Medical Center Performs Cutting Edge Minimally Invasive Bone Cancer Surgery. |
|
|
Jun 28, 2018 |
589 |
| Lonsurf Trial Shows Improved Overall Survival in Patients with Metastatic Gastric Cancer. |
|
Clinical report |
Jun 27, 2018 |
251 |
| MetaStat Preclinical Studies Demonstrate Benefit of MENA-pathway Inhibition in Aggressive Cancer. |
|
|
Jun 26, 2018 |
218 |
| A 20 YEARS' EXPERIENCE ON GRANULOSA CELL TUMOUR. |
Martin, P. Jovita M.; Kalaichelvi, K.; Lakshminarasimhan; Ramkumar; Dheenadhayalan |
Report |
Jun 25, 2018 |
4199 |
| Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. |
Yokom, Daniel W.; Stewart, John; Alimohamed, Nimira S.; Winquist, Eric; Berry, Scott; Hubay, Stacey; |
Report |
Jun 24, 2018 |
6007 |
| Putting the Brakes on Metastatic Cancer. |
|
|
Jun 23, 2018 |
624 |
| United States : Published Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with Metastatic Breast Cancer. |
|
|
Jun 22, 2018 |
396 |
| MetaStat presents results from MAPKAPK2 treatment studies at AACR. |
|
|
Jun 21, 2018 |
143 |
| Positivity Can Save Your Life, Woman Proves by Overcoming Battle against Rare Cancer. |
|
|
Jun 20, 2018 |
508 |
| Positivity Can Save Your Life, Woman Proves by Overcoming Battle against Rare Cancer. |
|
|
Jun 20, 2018 |
508 |
| Brain tumors. |
|
|
Jun 18, 2018 |
558 |
| United States : Seattle Genetics Announces First Patient Dosed in Phase 2 Trial of Tisotumab Vedotin for Women with Recurrent or Metastatic Cervical Cancer. |
|
|
Jun 18, 2018 |
445 |
| United States : Advaxis Announces Dosing Of First Patient With ADXS-NEO, An Investigational Customized Immunotherapy Approach Targeting Personal Neoantigens. |
|
|
Jun 18, 2018 |
372 |
| United States : Mercks KEYTRUDA (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival in First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in Phase 3 KEYNOTE-407 Study. |
|
Report |
Jun 13, 2018 |
280 |
| United States : KEYTRUDA (pembrolizumab) Monotherapy Significantly Improved Overall Survival in KEYNOTE-042 Study as First-Line Treatment for Locally Advanced or Metastatic NSCLC Patients Whose Tumors Expressed PD-L1 (TPS ?1%). |
|
Report |
Jun 13, 2018 |
415 |
| United States : LYNPARZA (olaparib) in Combination with Abiraterone Delayed Disease Progression in Metastatic Castration-Resistant Prostate Cancer. |
|
Clinical report |
Jun 13, 2018 |
565 |
| United States : FDA Approves Mercks KEYTRUDA (pembrolizumab) for Previously Treated Patients with Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS Greater Than or Equal to 1). |
|
|
Jun 13, 2018 |
811 |
| Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation Given Priority Review Status with FDA. |
|
|
Jun 12, 2018 |
277 |
| Tyme Technologies released detailed data from FHS and SM-88 programs. |
|
|
Jun 12, 2018 |
196 |
| Advaxis announces dosing in first patient with ADXS-NEO. |
|
|
Jun 11, 2018 |
232 |
| United States : Erdafitinib Phase 2 Study Results Show Promise in the Treatment of Metastatic Urothelial Cancer. |
|
|
Jun 11, 2018 |
480 |
| Japan,United States : Seattle Genetics and Astellas Present at ASCO 2018 on Enfortumab Vedotin in Patients with Locally Advanced or Metastatic Urothelial Cancer Previously Treated with Checkpoint Inhibitor Therapy. |
|
|
Jun 11, 2018 |
340 |
| Oncotheranostics: Advanced theranostic nanomedicines for oncology. Development of new combinatorial therapies for primary and metastatic breast cancer. |
|
|
Jun 9, 2018 |
357 |
| United States : FDA Expands Lilly's ALIMTA (pemetrexed) Label to Include Combination with KEYTRUDA (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression. |
|
|
Jun 9, 2018 |
546 |
| United States : Preliminary Data for NKTR-214 in Combination with Opdivo (nivolumab) for Patients with Stage IV Metastatic Melanoma, Renal Cell Carcinoma, and Urothelial Cancers Presented at ASCO 2018. |
|
|
Jun 9, 2018 |
460 |
| Metastatic Urothelial Cancer Drug Erdafitinib Yields Positive Results in Phase 2 Study. |
|
Clinical report |
Jun 8, 2018 |
271 |
| It matters how you target cancer. |
|
|
Jun 7, 2018 |
525 |
| KEYNOTE-042 Phase 3 Study of Keytruda as First-Line Treatment for Locally Advanced or Metastatic NSCLC Patients Whose Tumors Expressed PD-L1 Yields Positive Results. |
|
Report |
Jun 7, 2018 |
344 |
| Puma biotechnology Releases Interim Results of Phase Ib/II Trial of PB272 in Combination with TDM-1 in HER2-Positive Metastatic Breast Cancer. |
|
|
Jun 7, 2018 |
282 |
| Phase 3 KEYNOTE-407 Study of Keytruda Plus Chemotherapy Shows Increased Overall Survival in First-Line Treatment of Metastatic Squamous NSCLC. |
|
Report |
Jun 7, 2018 |
325 |
| Oral Chemotherapy Tesetaxel Shows a 45% Confirmed Response Rate in Patients with HER2 Negative, HR Positive, Metastatic Breast Cancer. |
|
|
Jun 7, 2018 |
257 |
| Immunomedics to present business update at ASCO. |
|
|
Jun 4, 2018 |
118 |
| Usefulness of [.sup.18]F-FDG PET/CT in Cutaneous Melanoma Patients with Negative Sentinel Lymph Nodes and High Clark Levels: Sentinel Lenf Nodu Negatif Yuksek Clark Seviyeli Kutanoz Melanom Hastalarinda [.sup.18]F-FDG PET/BT'nin Degeri. |
Topuz, Ozge Vural; Gortan, Fatma Arzu; Doner, Zubeyde Rana Kaya; Onsel, Cetin; Sayman, Haluk Burcak |
Report |
Jun 1, 2018 |
3689 |
| Disseminated Multi-system Sarcoidosis Mimicking Metastases on [.sup.18]F-FDG PET/CT: [.sup.18]F-FDG PET/BT'de Metastazi Taklit Eden Dissemine Multisistem Sarkoidoz. |
Makis, William; Palayew, Mark; Rush, Christopher; Probst, Stephan |
Case study |
Jun 1, 2018 |
547 |
| Reversibility and safety of KISS1 metastasis suppressor gene vaccine in immunocastration of ram lambs. |
Han, Yan-Guo; Liu, Gui-Qiong; Jiang, Xun-Ping; Xiang, Xing-Long; Huang, Yong- Fu; Nie, Bin; Zhao, Ji |
Report |
Jun 1, 2018 |
4169 |
| T-cell Thymic Lymphoma With Proventricular Metastasis in a Florida Scrub Jay (Aphelocoma coerulescens). |
Kruse, Tamara; Zachariah, Trevor; McManamon, Rita |
Report |
Jun 1, 2018 |
2716 |
| Expression of EpCAM protein in gastric cancer cells may contribute to its histogenesis. |
Niziol, M.; Kuczynska, P.; Misiura, M.; Zinczuk, J.; Zareba, K.; Ustymowicz, W.; Cwiklinska-Dworakow |
Report |
Jun 1, 2018 |
2950 |
| Left-Sided Colonic Obstruction Due to Brid Ileus and Coexisting Right Colon Cancer without Palpable Mass/Sol Kolon Kaynakli Brid Ileus ile Seyreden Ele Gelmeyen Sag Kolon Kanseri. |
Beksac, Kemal; Ustuner, Mehmet Akif; Cetin, Bahadir |
Case study |
Jun 1, 2018 |
1509 |
| Pfizer's Xalkori receives FDA breakthrough therapy designation in 2 indications. |
|
|
May 29, 2018 |
152 |
| Researchers at Cancer Treatment Centers of America' in Suburban Chicago Evaluating Investigational Medication for HER2-Positive Breast Cancer. |
|
Clinical report |
May 24, 2018 |
754 |
| BBC presenter Rachael Bland reveals devastating 'incurable' cancer diagnosis and how trial drugs have 'turned her into a lab rat'; The You, Me and the Big C podcast co-host revealed she is taking a new trial drug after being told her cancer was metastatic. |
|
|
May 22, 2018 |
451 |
| Immunomedics files BLA for treatment of metastatic triple-negative breast cancer. |
|
|
May 21, 2018 |
202 |
| Immunomedics files BLA for treatment of metastatic triple-negative breast cancer. |
|
|
May 21, 2018 |
198 |
| EVALUATION OF TRIPLE ASSESSMENT FOR DIAGNOSIS OF BREAST CANCER IN A TERTIARY CENTRE. |
Goel, Kanwar Singh; Goel, Sapna |
Report |
May 21, 2018 |
3593 |
| Switzerland : Phase III IMpower150 study showed Roches Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel. |
|
|
May 18, 2018 |
480 |
| Switzerland : Follow-up phase III data showed Roches Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death. |
|
|
May 18, 2018 |
413 |
| Lonsurf (trifluridine/tipiracil) Plus Supportive Care Improves Overall Survival in Patients with Metastatic Gastric Cancer. |
|
|
May 14, 2018 |
306 |
| PREVALENCE OF INTRAORBITAL NEOPLASMS- A RETROSPECTIVE STUDY FOR SEVEN YEARS. |
Seena, A.R.; Sreedevi, A.R. |
Report |
May 14, 2018 |
2316 |
| Switzerland : Roche provides update on Phase III study of Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people with heavily pre-treated locally advanced or metastatic colorectal cancer. |
|
|
May 12, 2018 |
305 |
| Lonsurf (trifluridine/tipiracil) Plus Supportive Care Improves Overall Survival in Patients with Metastatic Gastric Cancer. |
|
|
May 11, 2018 |
306 |
| Oncolytics and FDA agree plan for phase 3 trial of metastatic breast cancer treatment. |
|
|
May 10, 2018 |
187 |
| Oncolytics and FDA agree plan for phase 3 trial of metastatic breast cancer treatment. |
|
|
May 10, 2018 |
183 |
| Parenting concerns affect mothers with cancer:Study. |
|
|
May 9, 2018 |
319 |
| Debiopharm International SA passes US FDA Fast Track designation for Debio 1347 for treating metastatic tumours. |
|
|
May 9, 2018 |
207 |
| Taiho Oncology collects encouraging topline data from pivotal Phase 3 trial of LONSURF in metastatic gastric cancer. |
|
|
May 9, 2018 |
263 |
| Debiopharm International SA passes US FDA Fast Track designation for Debio 1347 for treating metastatic tumours. |
|
|
May 9, 2018 |
203 |
| Taiho Oncology collects encouraging topline data from pivotal Phase 3 trial of LONSURF in metastatic gastric cancer. |
|
|
May 9, 2018 |
259 |
| Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy. |
Liu, Shuai; Chen, Peng; Liu, Yan-Wei; Gu, Xue-Nan; Qiu, Xiao-Guang; Li, Bo |
Report |
May 9, 2018 |
4742 |
| Roche's cancer immunotherapy TECENTRIQ (atezolizumab) granted FDA priority review for initial treatment of specific type of metastatic lung cancer. |
|
|
May 8, 2018 |
255 |
| Roche's cancer immunotherapy TECENTRIQ (atezolizumab) granted FDA priority review for initial treatment of specific type of metastatic lung cancer. |
|
|
May 8, 2018 |
251 |
| Switzerland : FDA grants priority review to Roches cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer. |
|
|
May 8, 2018 |
275 |
| Is protein responsible for breast cancer? |
|
|
May 7, 2018 |
395 |
| IN VIVO PROTON MR SPECTROSCOPY IN DIAGNOSIS OF INTRACRANIAL CYSTIC LESIONS. |
Ramasamy, Sukumar; Alagappan, Periakaruppan; Chellathurai, Amarnath; Muthaiyan, Priya; Rajan, Suja |
Report |
May 7, 2018 |
3568 |
| Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers. |
|
Clinical report |
May 4, 2018 |
1254 |
| Taiwanese scientists isolate gene that spurs spread of cancer. |
|
|
May 3, 2018 |
395 |
| The role of neutrophil-lymphocyte ratio as a prognostic indicator in patients undergoing nephrectomy for renal cell carcinoma. |
Grimes, Nathan; Hannan, Cathal; Tyson, Matthew; Thwaini, Ali |
Brief article |
May 2, 2018 |
2533 |
| Inaugural Chicago Metsquerade on May 11 - A Fundraiser for Stage IV Breast Cancer Research. |
|
|
May 1, 2018 |
553 |
| Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. |
Lewis, James S., Jr.; Beadle, Beth; Bishop, Justin A.; Chernock, Rebecca D.; Colasacco, Carol; Lacch |
Report |
May 1, 2018 |
31769 |
| Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist. |
Nicholson, Andrew G.; Tsao, Ming S.; Travis, William D.; Patil, Deepa T.; Galateau-Salle, Francoise; |
Brief article |
May 1, 2018 |
13658 |
| A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province. |
Hosseini, Mohammad Amin; Mohamadianpanah, Mohammad; Zare-Bandeamiri, Mohammad; Mosleh-Shirazi, Moham |
Report |
May 1, 2018 |
3067 |
| Evaluating the role for renal biopsy in T1 and T2 renal masses: A single-centre study. |
Hoare, Dylan; Evans, Howard; Richards, Heidi; Samji, Rahim |
Report |
Apr 28, 2018 |
3558 |
| Replacement Planting In The Metastases-riem, Landscaping Works. |
|
|
Apr 27, 2018 |
126 |
| LIVE FOR TODAY; Running with terminal cancer by Kevin Webber. |
|
|
Apr 22, 2018 |
334 |
| United Kingdom : Updated overall survival data for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer presented at AACR. |
|
|
Apr 21, 2018 |
363 |
| amcure Pre-Clinical Data on AMC303's Anti-tumor and Anti-Metastatic Effects Presented at AACR. |
|
|
Apr 20, 2018 |
280 |
| AstraZeneca says FDA approves Tagrisso as 1st-line treatment for certain cancers. |
|
|
Apr 19, 2018 |
106 |
| Zulekha uses new technique for cancer treatment. |
|
|
Apr 19, 2018 |
418 |
| Roche wins US FDA approval for Premarket Approval (PMA) supplement for the cobas EGFR Mutation Test v2 for treating metastatic NSCLC. |
|
|
Apr 19, 2018 |
360 |
| Roche wins US FDA approval for Premarket Approval (PMA) supplement for the cobas EGFR Mutation Test v2 for treating metastatic NSCLC. |
|
|
Apr 19, 2018 |
364 |
| AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway. |
|
|
Apr 18, 2018 |
1401 |
| ROLE OF ADDITION OF NON-CONTRAST MRI SCAN BRAIN WITH SPECIFIC SEQUENCES (GRE, SWI, TOF ANGIOGRAM & TOF VENOGRAM SEQUENCES) TO ROUTINE NON-CONTRAST CT SCAN BRAIN AT INITIAL EMERGENCY WORK UP IN EVALUATION OF INTRA CEREBRAL HAEMORRHAGE. |
R, Somasekhar; Elaprolu, Praveen |
|
Apr 16, 2018 |
1552 |
| DNA Methylation and Uveal Melanoma. |
Yang, Zhi-Kun; Yang, Jing-Yun; Xu, Zhuo-Zai; Yu, Wei-Hong |
Report |
Apr 15, 2018 |
4732 |
| The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab. |
|
|
Apr 11, 2018 |
1280 |
| FINE NEEDLE ASPIRATION CYTOLOGY OF LYMPH NODES WITH HISTOLOGICAL CORRELATION--A STUDY OF 1033 CONSECUTIVE CASES, A SOUTH INDIAN STUDY. |
Gudibande, Tejaswini; Udupa K., Aniruddha; Puranik B., Rekha |
Report |
Apr 9, 2018 |
3842 |
| EMA Accepts Regulatory Submission for Lynparza (olaparib) in BRCA-Mutated HER2-Negative Metastatic Breast Cancer. |
|
|
Apr 6, 2018 |
399 |
| William Blair downgrades Incyte after metastatic melanoma study failure. |
|
|
Apr 6, 2018 |
152 |
| The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection? |
Lam, Cameron Jonathan; Kapoor, Anil |
Report |
Apr 6, 2018 |
2709 |
| Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. |
Karakiewicz, Pierre I.; Zaffuto, Emanuele; Kapoor, Anil; Basappa, Naveen S.; Bjarnason, Georg A.; Bl |
Report |
Apr 6, 2018 |
4565 |
| Nerlynx (neratinib) in Combination With Capecitabine or Paclitaxel Included in NCCN Guidelines as Treatment Option for Patients With Breast Cancer Brain Metastases. |
|
|
Apr 5, 2018 |
183 |
| Singapore : Calix Senior Director Bernd Hesse Elected to Broadband Forum Board of Directors. |
|
|
Apr 4, 2018 |
668 |
| United States : The European Medicines Agency accepts regulatory submission for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer. |
|
|
Apr 4, 2018 |
255 |
| Medicare Issues Local Draft Coverage Supporting Use of Cell-based Liquid Biopsy Test in Patients with Metastatic CRPC. |
|
|
Apr 3, 2018 |
313 |
| Singapore : NUS scientists develop novel patient cancer cell culture test kit for personalised, precise cancer therapy. |
|
|
Apr 3, 2018 |
668 |
| Esthesioneuroblastoma with widespread distant metastasis: Case report and literature review. |
Khosla, Manraj; Pecci, Cristina; Do, Annie; McGhan, Lee; Seetharam, Mahesh; Sue, Richard |
Case study |
Apr 1, 2018 |
108 |
| Risky Alternatives. |
|
Brief article |
Apr 1, 2018 |
143 |
| Validation of predictors for lymph node status in penile cancer: Results from a population-based cohort. |
Qu, X. Melody; Siemens, D. Robert; Louie, Alexander V.; Yip, Darwin; Mahmud, Aamer |
Report |
Apr 1, 2018 |
4926 |
| Calcium Mobilization and Inhibition of Akt Reduced the Binding of PEO-1 Cells to Fibronectin/[Ca.sup.2+] Mobilizasyonu ve Akt Inhibisyonu ile PEO-1 Hucrelerinin Fibronektine Baglanmasinda Azalma. |
Kilicaslan, Seda Mehtap Sari; Ayrim, Aysun; Apaydin, Elif; Incesu, Zemin |
Report |
Apr 1, 2018 |
4503 |
| Bristol-Myers Squibb Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for Certain Metastatic Colorectal Cancer Patients Accepted by US FDA for Priority Review. |
|
|
Mar 29, 2018 |
280 |
| FDA Grants Breakthrough Therapy Designation to Seattle Genetics and Astellas for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. |
|
|
Mar 28, 2018 |
320 |
| United States : U.S. Food and Drug Administration (FDA) Accepts Bristol-Myers Squibbs Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for Previously Treated Patients with MSI-H or dMMR Metastatic Colorectal Cancer for Priority Review. |
|
|
Mar 28, 2018 |
296 |
| United States : Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. |
|
|
Mar 28, 2018 |
380 |
| A CLINICO-PATHOLOGICAL STUDY OF SQUAMOUS CELL CARCINOMA OF GINGIVOBUCCAL COMPLEX IN PUNJAB. |
Pervej, Khurshid; Singh, Manjit; Singh, Baldev; Kundai, Ramesh Kumar; Singh, Anmol |
Report |
Mar 26, 2018 |
3334 |
| Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. |
|
|
Mar 21, 2018 |
229 |
| Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. |
|
|
Mar 21, 2018 |
225 |
| Pfizer, Astellas Seek to Expand Indication of Xtandi to include Men with Non-metastatic CRPC. |
|
|
Mar 21, 2018 |
304 |
| Astex Collaborator Janssen Receives US FDA Breakthrough Therapy Designation for Erdafitinib for Metastatic Urothelial Cancer. |
|
|
Mar 20, 2018 |
235 |
| Astellas announces US FDA priority review for XTANDI (enzalutamide) sNDA for non-metastatic castration-resistant prostate cancer. |
|
|
Mar 20, 2018 |
254 |
| Astellas announces US FDA priority review for XTANDI (enzalutamide) sNDA for non-metastatic castration-resistant prostate cancer. |
|
|
Mar 20, 2018 |
258 |
| United States : U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC). |
|
|
Mar 20, 2018 |
456 |
| Primary Pulmonary Germ Cell Tumor with Bone Metastasis. |
Li, Tong-Tong; Yan, Xu; Zhou, Tong; Liu, Ying; Yu, Zhen-Xiang |
Clinical report |
Mar 18, 2018 |
1175 |
| Pulmonary Metastasis of a Gigantic Cystosarcoma Phyllodes of the Breast. |
Gao, Yan-Hong; Xiang, Hui-Juan; Zhu, Jian; Duan, Yun; Zhou, Pei |
Clinical report |
Mar 18, 2018 |
771 |
| Janssen wins US FDA's breakthrough therapy designation for erdafitinib for metastatic urothelial cancer. |
|
|
Mar 16, 2018 |
253 |
| Janssen wins US FDA's breakthrough therapy designation for erdafitinib for metastatic urothelial cancer. |
|
|
Mar 16, 2018 |
249 |
| United States : Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer. |
|
|
Mar 16, 2018 |
259 |
| IO Biotech and MSD Partner to Evaluate IO102 in combination with Keytruda (pembrolizumab) in Patients with Metastatic NSCLC. |
|
|
Mar 14, 2018 |
265 |
| United States : Seattle Genetics Completes Acquisition of Cascadian Therapeutics. |
|
|
Mar 14, 2018 |
403 |
| Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. |
|
|
Mar 9, 2018 |
294 |
| Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. |
|
|
Mar 9, 2018 |
295 |
| Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. |
|
|
Mar 9, 2018 |
290 |
| Seattle Genetics completes Cascadian acquisition, getsTucatinib rights. |
|
|
Mar 9, 2018 |
288 |
| Sorrento Therapeutics says CAR-T cell therapy demonstrates therapeutic activity. |
|
|
Mar 5, 2018 |
387 |
| DISTAL PANCREATECTOMY IN THE SURGICAL TREATMENT OF PANCREATIC CANCER--A STUDY. |
Choudhury, Purujit |
Report |
Mar 5, 2018 |
2868 |
| STEREOLOGICAL ANALYSIS OF ANDROGEN RECEPTORS IN PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA/STEREOLOSKA ANALIZA ANDROGENIH RECEPTORA KOD KARCINOMA I BENIGNE HIPERPLAZIJE PROSTATE. |
Dajko, Sandra Trivunic; Bogdanovic, Jovo; Vojinov, Sasa; Visnjic, Bojana Andrejic |
Report |
Mar 1, 2018 |
4075 |
| Neoadjuvant data promising, role unclear. |
|
|
Mar 1, 2018 |
313 |
| Extraskeletal Myxoid Chondrosarcoma of Nasopharynx: An Oncologic Entity Rarely Reported. |
Purkayastha, Abhishek; Sharma, Neelam; Dutta, Vibha |
Report |
Mar 1, 2018 |
1557 |
| Genomic Health Launches Liquid Biopsy Test to Predict Treatment Response in Metastatic Castration-resistant Prostate Cancer. |
|
|
Mar 1, 2018 |
285 |
| First Patient Dosed in Merrimack Phase 2 Clinical Study of MM-121 in Patients with Post-Menopausal Metastatic Breast Cancer. |
|
Clinical report |
Mar 1, 2018 |
257 |
| Metastatic adenocarcinoma involving atypical meningioma. |
Agostini-Vulaj, Diana; Rosella, Peter; Yeaney, Gabrielle |
Case study |
Mar 1, 2018 |
1143 |
| Sustained Ventricular Tachycardia Secondary to Cardiac Metastasis of Lung Cancer. |
Li, Ying-Ying; Wang, Hua; Cui, Ya-Dong; Liu, Hang-Yu; Yang, Jie-Fu |
Case study |
Mar 1, 2018 |
1192 |
| MetaStat announces completion of pilot research project with Celgene. |
|
|
Feb 28, 2018 |
187 |
| Appendiceal and rectal carcinomas with Krukenberg tumour mimicking primary ovarian cancer. |
|
|
Feb 28, 2018 |
1558 |
| Eli Lilly receives additional FDA approval for Verzenio. |
|
|
Feb 26, 2018 |
139 |
| United States : ERLEADA (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, available for order at Biologics, Inc. |
|
|
Feb 22, 2018 |
362 |
| United States : Advaxis Submits Conditional Marketing Authorization Application For Axalimogene Filolisbac For The Second-Line Treatment Of Metastatic Cervical Cancer In European Union. |
|
|
Feb 19, 2018 |
500 |
| STUDY OF HISTOMORPHOLOGY AND IMMUNOHISTOCHEMICAL ANALYSIS IN BREAST NEOPLASM. |
Kaushal, Manish; Shukla, Arvind; Patil, Pankaj |
Report |
Feb 19, 2018 |
2246 |
| Results of Phase II Trial of Durvalumab in Recurrent or Metastatic Head and Neck Cancer with Low or Negative Expression of PD-L1 Protein Presented at 2018 Multidisciplinary Head and Neck Cancers Symposium. |
|
|
Feb 16, 2018 |
308 |
| The Janssen Pharmaceutical Companies wins the US FDA's approval for ERLEADA for non-metastatic castration-resistant prostate cancer. |
|
|
Feb 15, 2018 |
304 |
| The Janssen Pharmaceutical Companies wins the US FDA's approval for ERLEADA for non-metastatic castration-resistant prostate cancer. |
|
|
Feb 15, 2018 |
300 |
| Janssen Files MAA for Apalutamide for Treatment of High-Risk Non-Metastatic CRPC in Europe. |
|
|
Feb 14, 2018 |
282 |
| United States : Apalutamide helps delay spread of several prostate cancers in phase 3 clinical trial. |
|
|
Feb 13, 2018 |
306 |
| Combatcancer: Rational combination therapies for metastatic cancer. |
|
|
Feb 12, 2018 |
372 |
| DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT THYROID NODULE WITH DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING AND APPARENT DIFFUSION COEFFICIENT MEASUREMENTS AND ITS HISTOPATHOLOGICAL CORRELATION. |
M., Noufal P.; Ramakrishnan, K.G.; Kurup, Shailage; Ali, Naseer; Janardhanan, Sujith; Rabia, Tejmal |
Report |
Feb 12, 2018 |
5590 |
| Xtandi Plus ADT Reduces Risk of Metastasis, Death, PSA Progression in Men with CRPC Compared to ADT Alone. |
|
|
Feb 9, 2018 |
420 |
| United States : ZYTIGA (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer. |
|
|
Feb 9, 2018 |
543 |
| United States : ERLEADA (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Lowered Risk of Metastasis or Death in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Feb 9, 2018 |
297 |
| Germany : Bayer to showcase latest prostate cancer research at ASCO GU 2018 Cancer Symposium. |
|
|
Feb 8, 2018 |
479 |
| Japan : Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. |
|
|
Feb 8, 2018 |
352 |
| ANGLE plc and Abbott Laboratories to collaborate on metastatic breast cancer study. |
|
|
Feb 6, 2018 |
215 |
| ANGLE plc and Abbott Laboratories to collaborate on metastatic breast cancer study. |
|
|
Feb 6, 2018 |
211 |
| Astellas Pharma, Pfizer announce results from Phase 3 PROSPER trial. |
|
|
Feb 5, 2018 |
164 |
| USPTO Grants Skin Biology Patent for Non-toxic Skin Cancer Therapy with Copper Peptides. |
|
|
Feb 2, 2018 |
152 |
| FDA GRANTS FAST TRACK DESIGNATION TO ANTI-HER2. |
|
|
Feb 1, 2018 |
878 |
| Colorectal cancer in South Africa: An assessment of disease presentation, treatment pathways and 5-year survival. |
Brand, M.; Gaylard, P.; Ramos, J. |
Report |
Feb 1, 2018 |
3512 |
| Radiotherapy for Gastrointestinal Stromal Tumors. |
Ozkan, Emine |
Report |
Feb 1, 2018 |
6095 |
| Testosterone suppression in the treatment of recurrent or metastatic prostate cancer--A Canadian consensus statement. |
Klotz, Laurence; Shayegan, Bobby; Guillemette, Chantal; Collins, Loretta L.; Gotto, Geoffrey; Gueret |
Report |
Feb 1, 2018 |
6012 |
| Supplementary data: Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement. |
Klotz, Laurence; Shayegan, Bobby; Guillemette, Chantal; Collins, Loretta L.; Gotto, Geoffrey; Gueret |
|
Feb 1, 2018 |
1364 |
| A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. |
Khalaf, Daniel Joseph; Aviles, Claudia M.; Azad, Arun A.; Sunderland, Katherine; Todenhofer, Tilman; |
Report |
Feb 1, 2018 |
4584 |
| Association between life events after diagnosis of breast cancer and metastasis. |
Dourado, Claudia de Souza; de Souza, Camila Brandao; de Castro, Denise Silveira; Zandonade, Eliana; |
|
Feb 1, 2018 |
5435 |
| Alligator Bioscience selects Theradex Oncology as CRO for planned phase I study of ATOR-1015. |
|
|
Jan 29, 2018 |
131 |
| Alligator Bioscience selects Theradex Oncology as CRO for planned phase I study of ATOR-1015. |
|
|
Jan 29, 2018 |
127 |
| FDA Grants Synthon Fast Track Designation for Anti-HER2 ADC for Pre-treated HER2-positive Metastatic Breast Cancer. |
|
|
Jan 29, 2018 |
208 |
| Clinical Data from Taiho Oncology and Servier Study of Lonsurf (trifluridine and tipiracil) in Metastatic Colorectal Cancer Presented at ASCO 2018 Gastrointestinal Cancers Symposium. |
|
|
Jan 24, 2018 |
436 |
| Amgen and Allergan's MVASI (Biosimilar Bevacizumab) Approved by European Commission for Treatment of Certain Cancers. |
|
|
Jan 24, 2018 |
362 |
| Exelixis Presents Phase 1b Results for Cobimetinib plus Atezolizumab in Metastatic Colorectal Cancer at the 2018 ASCO Gastrointestinal Cancers Symposium. |
|
|
Jan 23, 2018 |
443 |
| United States : European Commission Approves Bristol-Myers Squibbs Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma. |
|
|
Jan 23, 2018 |
288 |
| Opdivo plus Yervoy Shows 55% ORR at 13.4 Months in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. |
|
|
Jan 22, 2018 |
328 |
| United States : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Clinical Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. |
|
|
Jan 22, 2018 |
380 |
| Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. |
|
|
Jan 19, 2018 |
260 |
| Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. |
|
|
Jan 19, 2018 |
261 |
| Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. |
|
|
Jan 19, 2018 |
256 |
| Amgen and Allergan's Mvasi for certain cancers approved in Europe. |
|
|
Jan 18, 2018 |
114 |
| US FDA Approves Lynparza (olaparib) for Germline BRCA-Mutated Metastatic Breast Cancer. |
|
|
Jan 17, 2018 |
492 |
| CytRx begins dosing in clinical trial for metastatic pancreatic cancer candidate. |
|
|
Jan 17, 2018 |
141 |
| Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. |
|
|
Jan 17, 2018 |
207 |
| Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. |
|
|
Jan 17, 2018 |
209 |
| Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. |
|
|
Jan 17, 2018 |
209 |
| AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. |
|
|
Jan 15, 2018 |
347 |
| AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. |
|
|
Jan 15, 2018 |
343 |
| AstraZeneca and Merck announces FDA approval of Lynparza for metastatic breast cancer. |
|
|
Jan 15, 2018 |
431 |
| Canada,United States : U.S. FDA Approves LYNPARZA (olaparib) in Germline BRCA-Mutated Metastatic Breast Cancer. |
|
|
Jan 14, 2018 |
700 |
| Eisai and Merck & Co. Receive Breakthrough Therapy Designation from U.S. FDA for LENVIMA and KEYTRUDA. |
|
|
Jan 9, 2018 |
1432 |
| Bad cholesterol helps cancer spread. |
|
|
Jan 3, 2018 |
226 |
| New Biomarker Predicts Metastatic Prostate Cancers. |
|
|
Jan 1, 2018 |
220 |
| Personalized medicine offers new hope to breast cancer patients. |
|
|
Jan 1, 2018 |
2236 |
| Plasma hepatic enzymes as biopredictors of type, metastasis, and prognostication of hematological malignancies. |
Akinlolu, Abdulazeez; Salau, Bamidele; Odewabi, Adesina; Biliaminu, Sikiru; Abdulazeez, Ishola |
Report |
Jan 1, 2018 |
2489 |
| Papillary Carcinoma of Thyroid with Nasal Cavity Metastases: A Case Report. |
Pourseirafi, Saeid; Shishehgar, Mahmood; Ashraf, Mohammad Javad; Faramarzi, Mohammad |
Case study |
Jan 1, 2018 |
1640 |
| EVALUATION OF HISTOPATHOLOGICAL RISK FACTORS IN ENUCLEATED RETINOBLASTOMA EYES. |
Acharya, Nibedita; Vasu, Usha |
Report |
Jan 1, 2018 |
2071 |
| Amgen's sBLA for XGEVA (denosumab) to expand the currently approved indication for the prevention of skeletal-related events in patients with bone metastases from solid tumors, has been approved to include multiple myeloma. |
|
|
Jan 1, 2018 |
217 |
| Occurrence of squamous cell carcinoma in Milchschaf sheep in Uruguay/Ocorrencia do carcinoma de celulas escamosas em ovinos Milchschaf em Uruguai. |
Garcia, Juan Agustin; Quinteros, Carina; Romero, Agustin; Dutra, Fernando |
|
Jan 1, 2018 |
3023 |
| Transrectal ultrasound-guided prostate biopsies vs. magnetic resonance imaging ultrasound fusion targeted biopsies: Who are the best candidates? |
Bey, Elsa; Gaget, Olivier; Descotes, Jean-Luc; Franquet, Quentin; Rambeaud, Jean-Jacques; Long, Jean |
Report |
Jan 1, 2018 |
3252 |
| Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea. |
Kim, Jeong Ho; Lee, Wan; Kim, Tae Nam; Nam, Jong Kil; Kim, Tae Hyo; Lee, Ki Soo |
Report |
Jan 1, 2018 |
3753 |
| Case: Testicular oligometastasis from prostate cancer--Report of rare isolated recurrence after radiotherapy and intermittent androgen-deprivation therapy. |
Cho, Chan-Kyung J.; Sigurdson, Samantha; Davidson, Christopher M.; Leveridge, Michael; Mahmud, Aamer |
Clinical report |
Jan 1, 2018 |
1729 |
| Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer. |
Yang, R.F.; Yu, B.; Zhang, R.Q.; Wang, X.H.; Li, C.; Wang, P.; Zhang, Y.; Han, B.; Gao, X.X.; Zhang, |
Report |
Jan 1, 2018 |
5456 |
| Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells. |
Zhang, S.; Zhang, Y.; Qu, J.; Che, X.; Fan, Y.; Hou, K.; Guo, T.; Deng, G.; Song, N.; Li, C.; Wan, X |
Report |
Jan 1, 2018 |
4188 |
| Odonate Therapeutics Begins Phase 3 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer. |
|
|
Dec 29, 2017 |
232 |
| Janssen NDA for Apalutamide as Treatment for Non-Metastatic CRPC Garners Priority Review from US FDA. |
|
|
Dec 26, 2017 |
284 |
| FDA approves Nanobiotix's first Immuno-Oncology trial. |
|
|
Dec 26, 2017 |
1718 |
| Bad cholesterol can help cancer spread, scientists warn. |
|
|
Dec 23, 2017 |
207 |
| Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. |
|
|
Dec 22, 2017 |
282 |
| Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. |
|
|
Dec 22, 2017 |
278 |
| United States : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease. |
|
|
Dec 21, 2017 |
303 |
| CHMP Recommends Approval of Yervoy (ipilimumab) for the Treatment of Patients 12 Years and Older with Unresectable or Metastatic Melanoma. |
|
|
Dec 19, 2017 |
351 |
| CLINICOPATHOLOGICAL STUDY OF TUMOURS OF HYPOPHARYNX. |
Sadangi, Rajesh Kumar; Misra, Santosh Kumar |
Report |
Dec 11, 2017 |
2028 |
| Eisai: Updated Analysis of Phase Ib/II Study of Eribulin and Pembrolizumab Combination Regimen. |
|
|
Dec 8, 2017 |
1455 |
| Ibrance (palbociclib) plus Letrozole Improves Progression-Free Survival in ER+, HER2- Metastatic Breast Cancer. |
|
|
Dec 7, 2017 |
372 |
| Preclinical Data Show Agilvax AX09 Immunotherapy Reduces Tumor Growth and Pulmonary Metastases in Triple Negative Breast Cancer. |
|
|
Dec 7, 2017 |
252 |
| Fitbit Aids In Understanding Cancer Surgery Recovery Better. |
|
|
Dec 6, 2017 |
534 |
| CYTOLOGIC PATTERNS OF LUNG CANCER. |
Prabha, Raj R.L.; Priya, P.V.; Sankar, S. |
Report |
Dec 4, 2017 |
2637 |
| INCIDENCE OF CENTRAL NERVOUS SYSTEM TUMORS IN PATIENTS HOSPITALIZED AT SPLIT UNIVERSITY HOSPITAL CENTRE DURING A TEN-YEAR PERIOD (JANUARY 1, 2004 - DECEMBER 31, 2013). |
Mizdrak, Maja; Dzamonja, Gordan; Grcic, Petar Filipovic |
Report |
Dec 1, 2017 |
4754 |
| RELAPSE OF PLEOMORPHIC ADENOMA FROM CHILDHOOD TO ADULTHOOD: CASE REPORT. |
Grabovac, Stjepan; Grabovac, Durdica; Puharic, Zrinka; Dalipi, Vesna Malcic |
Clinical report |
Dec 1, 2017 |
2620 |
| The Effect of Resection Methods on Outcomes in Colorectal Cancers: Does Conversion Matter?/Kolorektal Kanserlerde Rezeksiyon Metodunun Sonuclara Etkisi: Konversiyon Onemli mi? |
Erdogdu, Umut Eren; Cayci, Haci Murat |
Report |
Dec 1, 2017 |
5032 |
| Systemic Therapy after Radiotherapy Significantly Reduces the Risk of Mortality of Patients with 1-3 Brain Metastases: A Retrospective Study of 250 Patients. |
Li, Bo; Dai, Zhao-Xia; Chen, Yi-Dong; Liu, Yan-Wei; Liu, Shuai; Gu, Xue-Nan; Qiu, Xiao-Guang |
|
Dec 1, 2017 |
4164 |
| Metastatic Melanoma - Pipeline Review, H2 2015 Now Available at iData Insights. |
|
|
Dec 1, 2017 |
1841 |
| Germany : Phase III trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone for patients with metastatic castration-resistant prostate cancer unblinded early. |
|
|
Dec 1, 2017 |
346 |
| Myeloid sarcoma of the thyroid. |
Goldenberg, Dana; Joshi, Monika; Malysz, Jozef; Claxton, David; Cottrill, Elizabeth E. |
Report |
Dec 1, 2017 |
867 |
| Electrochemotherapy treatment of oral extramedullary plasmacytoma of the tongue: a retrospective study of three dogs/Eletroquimioterapia no tratamento de plasmocitoma extramedular oral na lingua: estudo retrospectivo de tres caes. |
Cunha, Rubia Monteiro de Castro; Lavalle, Gleidice Eunice; Caires, Carla Emanuela Tertuliano; de Ara |
|
Dec 1, 2017 |
2038 |
| Gene Expression, and Fatigue in Puerto Rican Men during Radiotherapy for Prostate Cancer: an Exploratory Study. |
Gonzalez, Velda J.; Saligan, Leorey N.; Fridley, Brooke L.; Ortiz-Zuazaga, Humberto; Aaronson, Laure |
|
Dec 1, 2017 |
6201 |
| Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus--Positive and Human Papillomavirus--Negative Tumors. |
Pirog, Edyta C. |
Report |
Dec 1, 2017 |
9920 |
| AstraZeneca reports acceptance by EMA of Tagrisso submission for 1st-line NSCLC. |
|
|
Nov 28, 2017 |
236 |
| AstraZeneca reports acceptance by EMA of Tagrisso submission for 1st-line NSCLC. |
|
|
Nov 28, 2017 |
237 |
| CORRELATION OF COAGULATION MARKERS WITH AXILLARY LYMPH NODE METASTASIS IN CARCINOMA BREAST. |
Choudhary, Ganpat Singh; Bairwa, Man Singh; Choudhary, Amit; Singodia, Rishi |
Report |
Nov 27, 2017 |
2433 |
| European Commission Extends License for Janssen's Zytiga Plus Prednisone / Prednisolone to Include Earlier Stage Prostate Cancer Patients. |
|
|
Nov 22, 2017 |
263 |
| Severe Pneumonitis after Nivolumab Treatment Accompanied by Acute Pulmonary Embolism in a Patient with Lung Adenocarcinoma. |
Liao, Ji-Ping; Nie, Li-Gong; Que, Cheng-Li; Mu, Xiang-Dong |
Case study |
Nov 20, 2017 |
1267 |
| A key to stopping cancer in its tracks. |
|
|
Nov 19, 2017 |
374 |
| Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. |
|
|
Nov 16, 2017 |
260 |
| Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. |
|
|
Nov 16, 2017 |
256 |
| Germany : Novartis reports positive results from Phase III trial of Kisqali (ribociclib) combination therapy in premenopausal women with HR+/HER2- advanced or metastatic breast cancer. |
|
|
Nov 9, 2017 |
328 |
| Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention. |
Li, Tian-Ran; Yu, Ming-Hui; Huang, Xiao-Bin; Yang, Zhi-Jie; Lu, Guang-Ming; Li, Yan-Jun |
|
Nov 5, 2017 |
5584 |
| Impact of distant and regional metastasis of non-small-cell lung cancer on endotoxicosis development. |
Belskaya, Lyudmila V.; Kosenok, Viktor K.; Sarf, Elena A.; Zhuchkov, Sergey A. |
|
Nov 1, 2017 |
5176 |
| Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. |
Bukhari, Nedal |
Report |
Nov 1, 2017 |
1532 |
| Neuroendocrine Tumors of the Breast. |
Rosen, Lauren Elizabeth; Gattuso, Paolo |
Report |
Nov 1, 2017 |
3667 |
| Myxoinflammatory Fibroblastic Sarcoma: Review and Update. |
Lucas, David R. |
Report |
Nov 1, 2017 |
2505 |
| Metastatic endometrial serous carcinoma to the breast. |
Lin, Tayson; Lin, David; Zhang, Ziying; Shah, Biren A. |
Case study |
Nov 1, 2017 |
1108 |
| MiR-34-a acts as a suppressor in neuroblastoma progression by targeting CD44. |
|
|
Oct 31, 2017 |
4267 |
| De novo descending aorta thrombus in a patient with metastatic colorectal cancer: A case report. |
|
|
Oct 31, 2017 |
1434 |
| Five-year Survival of Newly Diagnosed Stage Four Breast Cancer Has improved. |
|
|
Oct 30, 2017 |
389 |
| Eagle Pharmaceuticals Receives Tentative FDA Approval for Pemfexy Ready-to-Dilute. |
|
|
Oct 30, 2017 |
299 |
| A Tuberous Sclerosis Family with TSC1 (c.1030-1G>A) Mutation Found through a Female Presenting as Multiple Ground Glass Nodules in Chest Computed Tomography Incidentally. |
Zhao, Ting-Ting; Wang, Yong-Sheng; Li, Yan; Ma, Miao; Li, Ai-Mei; Cai, Hou-Rong; Fan, Xiang-Shan; Me |
Report |
Oct 20, 2017 |
1482 |
| OncoSec Releases Data from Recently Completed Studies of ImmunoPulse IL-12 Monotherapy or in Combination with Pembrolizumab in Metastatic Melanoma Patients. |
|
|
Oct 20, 2017 |
428 |
| Pfizer Study of ALK-Inhibitor Lorlatinib Shows Positive Results Against NSCLC Tumors and Brain Metastases. |
|
|
Oct 18, 2017 |
409 |
| Protein Biomarker Heterogeneity Observed in Metastatic Breast Cancer Patients. |
|
Clinical report |
Oct 16, 2017 |
266 |
| US FDA receives new drug application from Janssen Biotech for Apalutamide. |
|
|
Oct 13, 2017 |
166 |
| United States : Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Oct 12, 2017 |
394 |
| Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. |
|
|
Oct 12, 2017 |
244 |
| Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. |
|
|
Oct 12, 2017 |
240 |
| Janssen Submits NDA to US FDA for Apalutamide for Treatment of Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Oct 12, 2017 |
197 |
| OncoSec Begins Enrollment in Clinical Trial of ImmunoPulse IL-12 in Combination with Keytruda (pembrolizumab) in Patients with Unresectable Metastatic Melanoma. |
|
|
Oct 11, 2017 |
349 |
| Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells? |
|
|
Oct 2, 2017 |
743 |
| Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells?. |
|
|
Oct 2, 2017 |
749 |
| Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5. |
Yu, Z.; Cheng, H.; Zhu, H.; Cao, M.; Lu, C.; Bao, S.; Pan, Y.; Li, Y. |
Report |
Oct 1, 2017 |
3818 |
| Rare case of angiosarcoma of the adrenal gland seen with multiple modalities. |
Varkey, Jastin; Astani, Seyed Amin; Pantelic, Milan; Dalal, Ishani |
Case study |
Oct 1, 2017 |
1283 |
| Serous Tubal Intraepithelial Carcinoma or Not? Metastases to Fallopian Tube Mucosa Can Masquerade as In Situ Lesions. |
Singh, Reena; Cho, Kathleen R. |
Report |
Oct 1, 2017 |
2171 |
| Chemo causes disease to spread to lungs. |
|
|
Oct 1, 2017 |
322 |
| Eli Lilly and Company awarded US FDA approval for Verzenio for the treatment of advanced or metastatic breast cancer. |
|
|
Sep 29, 2017 |
334 |
| Claim for missed cancer diagnosis goes back to jury. |
Donovan, David |
|
Sep 27, 2017 |
672 |
| Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells? |
Nagrath, Sunitha |
|
Sep 25, 2017 |
743 |
| Metastatic Breast Cancer Treatment. |
|
Brief article |
Sep 22, 2017 |
222 |
| Germany : European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. |
|
|
Sep 22, 2017 |
713 |
| Merck KGaA & Pfizer Inc partnership win EC's marketing authorisation for BAVENCIO for metastatic merkel cell carcinoma. |
|
|
Sep 21, 2017 |
317 |
| United States : Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer. |
|
|
Sep 16, 2017 |
355 |
